Today 10 Companies Raised Over $562 Million.
ElevateBio, Sastrify, and SEKOIA raised $401M, $32M, and $35M.
Interested in human due diligence services for your investment firm? Visit our website to learn more and connect with us today!
Deal #1: Sastrify Secures $32M Series B to Expand Its SaaS Procurement Platform Globally.
About:
As a virtual SaaS procurement service, Sastrify aids finance and tech teams by streamlining the management and cost-efficiency of SaaS tools in digitally driven companies. We automate mundane tasks such as setting renewal dates and contacting suppliers, while our dedicated procurement team leverages a large SaaS benchmark database to secure the best market prices. We guarantee a 3-4x ROI for our clients with minimal effort on their part.
Funding Round Info:
Sastrify is excited to announce a robust $32 million Series B funding round, headed by Endeit Capital and featuring contributions from Simon Capital and previous backers HV Capital, FirstMark Capital, and TriplePoint Capital. This new capital will boost our global team expansion, primarily in the United States and Europe, and fast-track our product development for mid-market and enterprise customers. Since our launch in mid-2020, we've achieved over 400% growth in Europe, largely thanks to our focus on delivering a clear return on investment for our clients.
Deal #2: European Cybersecurity Firm Sekoia.io Secures Record €35M Series A Funding.
About:
SEKOIA is a SaaS-based cybersecurity company that specializes in detecting and understanding emergent threats. The company's areas of expertise include cybersecurity consulting, innovation, RedTeam, BlueTeam, threat intelligence, and offering SIEM as a service through the Sekoia.io platform.
Funding Round Info:
Sekoia.io, known for its eXtended Detection & Response (XDR) platform that detects cyberattacks in real-time, has successfully raised €35M in a Series A round. The financing round featured participation from Banque des Territoires, European investor Bright Pixel (formerly Sonae IM), and existing investors Omnes Capital, Seventure, and BNP Paribas Développement. This funding follows a previous round in 2020, where the company raised €10M. This recent investment marks a record amount for a European cybersecurity company in a Series A round.
Deal #3: Novisto Secures $20M Series B Funding to Enhance ESG Data Management Solutions.
About:
Novisto is an end-to-end enterprise software provider focused on enhancing corporate sustainability management. The platform empowers organizations to derive value from their Environmental, Social, and Governance (ESG) strategies, data, and reporting. By streamlining the sustainability management journey, Novisto helps companies own and control their ESG narratives. The company's mission is to promote a more inclusive and resilient society by empowering organizations to create value through sustainability.
Funding Round Info:
Novisto has raised $20 million in a Series B funding round led by Inovia Capital. Other participants in the round include Portage Ventures, SCOR Ventures, and existing investors White Star Capital and Diagram Ventures. The company, founded in 2019, believes in the future development of ESG tech stacks, where ESG data management will be a crucial component. Among Novisto's current clients are workflow management company Asana, financial services group Manulife, and pharmaceutical giant Sanofi.
Deal #4: Artelon Secures $20M Series B Funding to Enhance Surgical Solutions for Joint Instability.
About:
Artelon, Inc. is a privately-owned medical device company specializing in the creation of bio-textiles specifically designed for the kinematic reinforcement of tendon and ligament reconstruction. This unique approach to medical technology aims to improve outcomes for patients experiencing joint instability.
Funding Round Info:
Artelon, Inc. has successfully closed a Series B funding round, amassing approximately $20 million. The round was led by Vensana Capital, with expected additional support from existing investors. These funds will be allocated towards facilitating commercial growth, expanding clinical research, and broadening Artelon's product line, which is currently focused on the surgical treatment of ankles and other joint-related issues.
Deal #5: Incredo (Formerly DouxMatok) Raises $30M in Series C Funding for Enhanced Sugar Commercialization.
About:
Incredo, previously known as DouxMatok, is a leading global food-tech company with its R&D center based in Petach-Tikva, Israel. The company, incorporated in 2014, boasts a proprietary technology that enriches the sweetness of sugars without any aftertaste. By preserving the full "sugar experience", their enhanced sweetness allows for a substantial reduction in sugar consumption, aligning with modern health-conscious trends.
Funding Round Info:
DouxMatok, now rebranded as Incredo LTD., has raised $30 million in a Series C funding round. This funding announcement coincides with the unveiling of the company’s new name, which is derived from their signature product, Incredo® Sugar. The Series C round is led by dsm-firmenich Venturing and Sienna Venture Capital, with participation from strategic commercial partners like Ferrero and new investors such as Teseo Capital. Existing investors, Pitango and BlueRed Partners, who led the previous round, also contributed to this round. The raised capital will facilitate the expansion of research, development, and commercialization efforts for Incredo's flagship product, Incredo® Sugar.
Deal #6: nProTher Secures EUR 6M Seed Financing, Including Participation from the European Innovation Council Fund, to Propel First-In-Class Cancer Immunotherapy Development.
About:
nProTher is a pioneering immunotherapy company focused on creating the world's first adaptive immune therapy aimed at targeting immunosuppressive genes of ancient retroviruses.
Funding Round Info:
InProTher, a nascent biotech company committed to developing efficient immunotherapies targeting the Human Endogenous Retroviruses (HERVs), announced today it has raised EUR 6M in Seed funding. This round involved the participation of private investors and the European Innovation Council (EIC) Fund. This financial boost will empower InProTher to push its flagship drug candidate, IPT001, a first-of-its-kind immunotherapy against solid tumors, into the clinical development phase.
Deal #7: UK's Sneaker Resale Marketplace, Laced, Bags $12M in Series A Funding.
About:
Laced, based in London and established in 2018, is a platform that enables the trade of authenticated premium sneakers between sellers and buyers. Sellers could be individuals selling rare sneakers for profit after purchasing from the original brand, or they could be professional sellers focused on sourcing sought-after footwear in bulk. The seller sets a price, and the shoes are then listed in a queue which prioritizes the lowest priced footwear first.
Funding Round Info:
Laced has successfully secured $12 million in a Series A funding round, topping up the $1 million pre-seed round raised three years prior. This round was spearheaded by London-based investment firm Talis Capital, and saw participation from H&M Group Ventures (the investment arm of H&M), B&Y Venture Partners, Truesight Ventures, and a few angel investors.
Deal #8: ElevateBio, Backed by SoftBank, Amasses $401M in Latest Financing Round.
About:
ElevateBio is a Cambridge, Massachusetts-based company that operates a portfolio of cell and gene therapy companies with the intent to develop, manufacture, and commercialize groundbreaking medicines. Co-founded by Vikas Sinha, Mitchell Finer, and David Hallal in 2017, ElevateBio partners with some of the world's most creative scientists and inventors. The company also boasts a centralized facility that streamlines the translation of cell and gene therapy R&D into commercially viable therapies swiftly and efficiently. This enables patients to receive innovative medical products to treat severe diseases.
Funding Round Info:
ElevateBio announced on Wednesday that it secured $401 million in a new funding round led by the AyurMaya Capital Management Fund, operated by Matrix Capital Management. This news comes as the venture capital market looks to bounce back after a lackluster 2022. To date, the biotechnology research firm has raised approximately $1.27 billion, according to a statement emailed to Reuters. The most recent funding round follows over two years since ElevateBio raised $525 million from investors such as SoftBank Vision Fund 2 and Matrix Capital.
Deal #9: GITAI, the Leading Space Robotics Startup, Garners US$30 Million in Series B Extension Round.
About:
GITAI is a pioneering robotics startup focusing on space development. The company's primary objective is to substitute astronauts with remotely controlled robots capable of prolonged work within low earth orbit space stations. This innovation aims to alleviate the workload on astronauts, expedite tasks performed in space, and decrease associated costs.
Funding Round Info:
GITAI USA Inc. and GITAI Japan Inc. (collectively, GITAI), the foremost company in space robotics, have successfully completed a Series B Extension funding round. The company raised an impressive 4 billion yen (roughly US$30 million) to expedite and broaden their business and technological development in the US.
The capital raised in this round will be mainly allocated towards the following goals:
Enhancing the Technology Readiness Level (TRL) of GITAI's Lunar Robotic Rover and Lunar Inchworm Type Robotic Arm.
Expanding the Engineering Model/Flight Model Manufacturing Facilities within the US.
Further expanding GITAI's employment opportunities in the US.
Deal #10: Cleantech Startup Stride Bags US$2M in Seed Funding from Clime Capital and Touchstone Partners.
About:
Stride is a Vietnamese cleantech company committed to promoting a sustainable future. The firm specializes in offering eco-friendly home repair solutions, smart home technology, energy-efficient products, and accessible solar energy to every household.
Funding Round Info:
Stride, an innovative cleantech firm based in Vietnam, has successfully raised US$2 million in seed funding. The investment came from the Vietnamese venture capital firm Touchstone Partners and Singapore-based Clime Capital. The startup intends to use this funding to boost its ability to provide cost-effective, clean energy solutions to residential and small business customers in Vietnam.
Deal #11: Indonesian Fintech Startup SkorLife Secures $4M in Seed Funding Backed by Hummingbird Ventures and QED Investors.
About:
SkorLife is Indonesia's first credit builder. The company, co-founded by Ongki Kurniawan and Karan Khetan, provides a platform for individuals to check their credit scores from the country's credit bureaus and receive tips on how to improve them, thereby enabling better access to credit. By encouraging consumers to take a proactive role in building and maintaining their creditworthiness, SkorLife is committed to promoting financial literacy and inclusion in Indonesia.
Funding Round Info:
SkorLife, an innovative fintech startup based in Indonesia, has successfully raised $4 million in a seed funding round. The investment round was led by global tech investor Hummingbird Ventures and included participation from QED Investors. Existing investors AC Ventures and Saison Capital also contributed to the round.